TrialEye (London, England)2023

Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trial.

Anastasios-Georgios Konstas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.